Global Ganja Report

The news that CBD products will be arriving at Walgreens and CVS drugstore chains can be seen as further progress for the normalization of cannabis. But it is also a further indication of corporate control of the new cannabis economy.

In a win both for cannabis freedom and racial justice, Vermont's top court ruled in favor of a motorist whose car was searched on the ostensible basis that a state trooper smelled pot—and the probable basis that he is African American.

With passage of the Farm Bill and removal of hemp-derived CBD from controlled substance status, big market growth is expected for the very chic and purportedly salubrious non-psychoactive cannabinoid. The law is a win for a nascent CBD industry that has been struggling to shake off the lingering stigma surrounding (psychoactive) cannabis. The effort to segment cannabidiol from "marijuana" is exemplified in the several states that now have "CBD-only" laws.

A major player in Canada's legal cannabis sector is seeking to acquire a troubled US-based company—the latest example of the trend toward consolidation in the industry now crossing international borders.

Attorney General Jeff Sessions' newly announced Religious Liberty Task Force has progressives fearing the worst. But might it open political space to argue for a right to sacramental use of cannabis?

After three years of mounting discontent from patients and providers alike, Florida's medical marijuana chief Christian Bax is stepping down. He leaves office as state health authorities prepare for a tsunami of applications for a few highly coveted marijuana licenses.

Medical marijuana users who demand their right to smoke herbaceous cannabis were dealt a double whammy as Oklahoma health authorities and a Florida court each issued edicts upholding strictures on smokable forms. But is it really medical marijuana if it doesn't include the right to smoke the herbaceous form of the plant?

Seniors are the fastest growing group of medicinal cannabis users in the country, and a growing number of nursing homes from coast to coast are tolerating use of tinctures and extracts to combat dementia, insomnia and related ailments. Patient testimony is now backed up by research, with scientists identifying the mechanism by which cannabinoids slow the deterioration of neurons in the brain. But federal strictures continue to pose an obstacle to investigation—leaving medicinal users in the cold under US law.